• Corpus ID: 210192196

Bone-strengthening supplement (BSP) promotes bone and cartilage repair, for the treatment of Osteonecrosis of Femoral Head: an MRI-based study.

@article{Li2019BonestrengtheningS,
  title={Bone-strengthening supplement (BSP) promotes bone and cartilage repair, for the treatment of Osteonecrosis of Femoral Head: an MRI-based study.},
  author={Zheng Li and Jin Wei and Hong Xiao and Liguo Zhu and Xisheng Weng and Jin Jin and Jun Zhang and Heming Wang and Ji-rong Ge and Tianzun Tao and Lingpeng Pei and Xin Dong and Lulin Wang},
  journal={American journal of translational research},
  year={2019},
  volume={11 12},
  pages={
          7449-7455
        }
}
  • Zheng LiJin Wei Lulin Wang
  • Published 15 December 2019
  • Medicine, Biology
  • American journal of translational research
Currently, no effective drug treatment is available for bone and joint disease, a disorder of the bone and cartilage cells. Osteonecrosis of the femoral head (ONFH) is an example of bone and joint disease. It is progressive, with femoral head collapse resulting from the death of osteocytes and the bone marrow, leading to a poor quality of life and surgical interventions. However, the mechanism of this disease is still unknown, and the effects of current therapy are not satisfactory. In our… 

Figures and Tables from this paper

Efficacy of bone marrow stem cells combined with core decompression in the treatment of osteonecrosis of the femoral head

Compared with CD treated alone in the treatment of ONFH, combined utilization of CD and autologous BMSCs implantation has a better pain relief and clinical outcomes and can delay the collapse of the femoral head more effectively.

Umbilical cord derived mesenchymal stem cell therapy for osteonecrosis of femoral head

The objective of this review is to highlight the potential of mesenchymal stem cell (MSC) therapy along with core decompression for the management of ONFH with a special reference to umbilical cord-derived stem cells.

Decreased RIPK1 expression in chondrocytes alleviates osteoarthritis via the TRIF/MyD88-RIPK1-TRAF2 negative feedback loop

Osteoarthritis (OA) is the most common degenerative joint disease and involves the loss of articular cartilage integrity, formation of articular osteophytes, remodeling of subchondral bone, and

References

SHOWING 1-10 OF 38 REFERENCES

Bone-strengthening pill (BSP) promotes bone cell and chondrocyte repair, and the clinical and experimental study of BSP in the treatment of osteonecrosis of the femoral head

Treatment with BSP significantly reduced pain, improved hip function, reduced lameness, and improved pathology by X-ray and MRI analysis, compared with patients who did not receive BSP, suggesting that BSP treatment inhibits and reverses necrosis of the Femoral head bone cells and cartilage cells to repair the femoral head, promote the repair of bone and Cartilage diseases.

Experimental research into using bone-strengthening pill to treat ischemic necrosis of femoral head.

Peripheral Blood Stem Cell Therapy Does Not Improve Outcomes of Femoral Head Osteonecrosis With Cap‐Shaped Separated Cartilage Defect

  • Jun YingPinger Wang Hongting Jin
  • Medicine, Biology
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society
  • 2019
The results indicate that this combination treatment is not an effective method for the treatment of patients with painful CSS‐ONFH and did not inhibit inflammatory osteoclastogenesis in patients with more advanced disease.

The Pathophysiological Sequence of Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Male Mice

The results indicate that the Femoral head is a particularly sensitive anatomical site to the adverse effects of glucocorticoid excess on bone and that decreases of Hif-1α and VEGF expression, bone vascularity, and strength precede the loss of bone mass and microarchitectural deterioration, thus rendering the femoral head vulnerable to collapse.

Investigating Clinical Failure of Bone Grafting through a Window at the Femoral Head Neck Junction Surgery for the Treatment of Osteonecrosis of the Femoral Head

Disease type, disease stage, and patient age are risk factors for failure of bone graft surgery.

Lantern-shaped screw loaded with autologous bone for treating osteonecrosis of the femoral head

The lantern-shaped screw loaded with autologous bone for the treatment of pre-collapse stages of ONFH is effective and results in preventing progression of OnFH and reducing the risk of femoral head collapse.

Core decompression or quadratus femoris muscle pedicle bone grafting for nontraumatic osteonecrosis of the femoral head: A randomized control study

The CD with bone graft should be generally used for the treatment of patients with an early stage (Ficat Stage I or II) ONFH, and could relieve hip pain, improve hip function with much lesser surgical trauma compared to QF-MPBG.

Treatment of Pre-Collapse Stages of Osteonecrosis of the Femoral Head: a Systematic Review of Randomized Control Trials

Current literature shows that there is a lower risk of femoral head collapse in patients with ONFH treated with CD combined with BMMCs when compared to CD alone; however, there is no robust evidence to determine the effect on functional outcomes.

Icariin Protects against Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Rats

In the in vivo study, ICA prevented bone loss in a rat model of GC-related ONFH as shown by micro-CT scanning, histological and immunohistochemical analyses, indicating that ICA is an effective candidate for management ofGC-associated ONFH.